1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Cardio3 to commence Phase III heart failure trial of C3BS-CQR-1 in Belgium – Pharmaceutical Business Review

November 23, 2012Organ Failureadmin

Cardio3 to commence Phase III heart failure trial of C3BS-CQR-1 in Belgium
Pharmaceutical Business Review
Multi-centre, randomized trial designed to compare C3BS-CQR-1 treatment with sham treatment is expected to enroll at least 240 patients suffering from chronic advanced symptomatic heart failure. The composite endpoint of mortality, morbidity, quality ...

and more »

Post navigation

← How to avoid heart problems after menopause – Times of India A Walk Through Rigel Pharma – NASDAQ →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos